Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC c

AIR-NET will establish a multi-centre network with integrated clinical and translational capabilities for the investigation of therapies in bronchiectasis aiming to identify key anti-inflammatory mechanisms and effective re-purposed treatments.

Authors

Institutions

Publication Details

Journal
ERJ Open Research
Published
2025-10-16
DOI
https://doi.org/10.1183/23120541.00719-2025
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC c

Jeffrey Huang, Michael R. Loebinger, Jon Stobo, Jaa Ming New et al.
ERJ Open Research
Cystic Fibrosis Research Advances
article

Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC c

Jeffrey Huang, Michael R. Loebinger, Jon Stobo, Jaa Ming New, Amy Gilmour, Charles Haworth, Fiona McLaren-Neil, Holly Lind, Rebecca C Hull, Eve Mcintosh, Aran Singanayagam, Sanjay H. Chotirmall, Anand D. Shah, Thomas S. Wilkinson, Anthony De Soyza, Bridget Harris, Margaret Band, Zsofia Eke, James D. Chalmers, R.B. Galloway, Merete Bridget Long
article en

Abstract

AIR-NET will establish a multi-centre network with integrated clinical and translational capabilities for the investigation of therapies in bronchiectasis aiming to identify key anti-inflammatory mechanisms and effective re-purposed treatments.

ERJ Open ResearchVol. 12(2)
University of Ulster (GB), Nanyang Technological University (SG), University of Dundee (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Royal Papworth Hospital (GB), NHS Tayside (GB), Tan Tock Seng Hospital (SG), Royal Brompton Hospital (GB), Lung Institute (US), NIHR Imperial Biomedical Research Centre (GB), Royal Victoria Hospital (GB), University of Southampton (GB), Imperial College London (GB), Newcastle University (GB)
Openalex Percentile: Top 58%
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.